Extracardiac applications of MR blood pool contrast agent in children

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Pediatric Radiology

• Publication date

  2014-11-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00247-014-3167-xPMID 25408135
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Safety of Blood Pool Contrast Agent Administration in Children and Young Adults.

  2015cited by this paper
• Magnetic resonance venography of the upper venous system with blood pool contrast agent: comparison of two different T1-weighted sequences.

  2013cited by this paper
• Gadofosveset trisodium: abdominal and peripheral vascular applications.

  2013cited by this paper
• Abdominopelvic and lower extremity deep venous thrombosis: evaluation with contrast-enhanced MR venography with a blood-pool agent.

  2013cited by this paper
• Analysis of an automated background correction method for cardiovascular MR phase contrast imaging in children and young adults

  2013cited by this paper
• Gadofosveset-Enhanced Magnetic Resonance Angiography of the Thoracic Vasculature in the Equilibrium Phase: Feasibility and Impact of Dose

  2013cited by this paper
• Gadofosveset-enhanced magnetic resonance angiography as a means of evaluating pulmonary arteriovenous malformation: a case report.

  2012cited by this paper
• Gadofosveset—A Blood Pool Contrast Agent Used with MRI to Detect Obscure Gastrointestinal Bleeding: A Case Report

  2012cited by this paper
• Rapid MR venography in children using a blood pool contrast agent and multi-station fat-water-separated volumetric imaging

  2012cited by this paper
• Gadofosveset trisodium in the investigation of focal liver lesions in noncirrhotic liver: Early experience

  2012cited by this paper
• Magnetic resonance VIBE venography using the blood pool contrast agent gadofosveset trisodium--an interrater reliability study.

  2012cited by this paper
• Gadofosveset

  2012cited by this paper
• Active gastrointestinal hemorrhage identification by blood pool contrast-enhanced magnetic resonance angiography

  2011cited by this paper
• Combined respiratory and cardiac triggering improves blood pool contrast-enhanced pediatric cardiovascular MRI

  2011cited by this paper
• Gadofosveset-enhanced 4D magnetic resonance angiography as a means of localizing the site of post aortic graft leak.

  2011cited by this paper
• Combined magnetic resonance imaging of deep venous thrombosis and pulmonary arteries after a single injection of a blood pool contrast agent

  2011cited by this paper
• Gadofosveset: Parameter Optimization for Steady-State Imaging of the Thoracic and Abdominal Vasculature

  2011cited by this paper
• Nephrogenic systemic fibrosis: review of 370 biopsy-confirmed cases.

  2011cited by this paper
• First-pass and steady-state MR angiography of thoracic vasculature in children and adolescents.

  2010cited by this paper
• Gadolinium-Enhanced Magnetic Resonance Angiography for Pulmonary Embolism

  2010cited by this paper
• Advantages of blood pooling in pediatric MR angiography.

  2010cited by this paper
• Highly accelerated first‐pass contrast‐enhanced magnetic resonance angiography of the peripheral vasculature: Comparison of gadofosveset trisodium with gadopentetate dimeglumine contrast agents

  2009cited by this paper
• Peripheral MR angiography with blood pool contrast agent: prospective intraindividual comparative study of high-spatial-resolution steady-state MR angiography versus standard-resolution first-pass MR angiography and DSA.

  2008cited by this paper
• First-Pass Whole-Body Magnetic Resonance Angiography (MRA) Using the Blood-Pool Contrast Medium Gadofosveset Trisodium: Comparison to Gadopentetate Dimeglumine

  2007cited by this paper
• MR angiography with blood pool contrast agents

  2007cited by this paper
• A Summary of Safety of Gadofosveset (MS-325) at 0.03 mmol/kg Body Weight Dose: Phase II and Phase III Clinical Trials Data

  2006cited by this paper
• MR angiography of aortoiliac occlusive disease: a phase III study of the safety and effectiveness of the blood-pool contrast agent MS-325.

  2005cited by this paper
• MR angiography with gadofosveset trisodium for peripheral vascular disease: phase II trial.

  2003cited by this paper
• The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates.

  2002cited by this paper
• Steady-state and dynamic MR angiography with MS-325: initial experience in humans.

  1998cited by this paper
• Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging.

  1997cited by this paper

• Vascular Malformations: Understanding Origins, Diagnosis, and Treatment Advances

  2025cites this paper
• Imaging of peripheral vascular malformations — current concepts and future perspectives

  2021cites this paper
• MINISYMPOSIUM : MR TECHNIQUES IN PEDIATRIC RADIOLOGY Gadolinium-based contrast agents in pediatric magnetic resonance imaging

  2017cites this paper
• Novelty in hypertension in children and adolescents: focus on hypertension during the first year of life, use and interpretation of ambulatory blood pressure monitoring, role of physical activity in prevention and treatment, simple carbohydrates and uric acid as risk factors

  2016cites this paper
• Combined blood pool and extracellular contrast agents for pediatric and young adult cardiovascular magnetic resonance imaging

  2016cites this paper
• 2014 Revised Classification of Vascular Lesions from the International Society for the Study of Vascular Anomalies: Radiologic-Pathologic Update.

  2016cites this paper
• 4D Contrast-enhanced MR Angiography with the Keyhole Technique in Children: Technique and Clinical Applications.

  2016cites this paper
• Magnetic resonance imaging of pediatric soft-tissue vascular anomalies

  2016influential citation
• Whole-body magnetic resonance imaging in children: technique and clinical applications

  2016cites this paper
• Blood pool contrast agents for venous magnetic resonance imaging.

  2016influential citation